PDT Partners’s HOOKIPA Pharma HOOK Stock Holding History

PDT Partners’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,930	Closed	-$115K	–	1000
2021 Q4	$115K	Hold	4,930	–	–	0.01%	811
2021 Q3	$290K	Buy	+4,930	New	+$358K	0.02%	604

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PDT Partners's HOOK Position: Q1 2022 in Review

PDT Partners sold out of HOOKIPA Pharma (HOOK) in Q1 2022, closing a stake of 4,930 shares — an estimated $115K sold.

PDT Partners first reported a position in HOOK in Q3 2021 and held it in 2 quarters. The position peaked at $290K in Q3 2021. 74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

PDT Partners reported no remaining HOOKIPA Pharma position as of Q1 2022 after selling out during the quarter.
PDT Partners sold 4,930 HOOKIPA Pharma shares in Q1 2022, an estimated $115K.
PDT Partners first reported a position in HOOKIPA Pharma in Q3 2021 and held it in 2 quarters.
PDT Partners's HOOKIPA Pharma position peaked at $290K in Q3 2021.
74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.